Back to results
US 11,542,487 B2Granted
Beta-amylase enzymes
AssigneeBASF SE
InventorsHugo Urbina, Tong Li, Jared Dennis, Xuqiu Tan, Adrienne Huston Davenport, Jochen Kutscher, Kristine W. Chang
Life of this patent
Estimating the term…
Abstract
Variant polypeptides having beta-amylase activity and methods of making and using the enzymes in baking, detergents, personal care products, in the processing of textiles, in pulp and paper processing, in the production of ethanol, lignocellulosic ethanol, or syrups; as viscosity breakers in oilfield and mining industries.
Claims7
A variant polypeptide having beta-amylase activity, wherein the variant polypeptide is selected from the group consisting of:
- (a) variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:2, wherein the variant polypeptide has at least one single amino acid modification to the amino acid sequence of SEQ ID NO:2, at an amino acid residue position number:
- 16, 19, 24, 25, 27, 28, 48, 101, 105, 107, 119, 141, 143, 145, 146, 147, 153, 172, 175, 179, 197, 201, 203, 205, 206, 215, 219, 220, 221, 230, 364, 366, 369, 398, 399, 438, 440, 446, 452, 453, 456, 458, 463, 464, 465, 468, 476, 490, 499, 504, 508, or any combination thereof to the amino acid sequence of SEQ ID NO:2, and the variant polypeptide has beta-amylase activity;
- (b) variant polypeptide is an amino acid sequence that is at least 99.4% identical to the amino acid sequence as set forth in SEQ ID NO:3, wherein the variant polypeptide has at least one single amino acid modification to the amino acid sequence of SEQ ID NO:3, at an amino acid residue position number:
- 16, 19, 24, 25, 27, 28, 48, 83, 101, 105, 107, 119, 141, 143, 145, 146, 147, 153 155, 172, 175, 179, 197, 201, 203,205, 206, 215, 219, 220, 221, 230, 273, 280, 286, 319, 322, 364, 366 369, 398, 399, 438, 440, 446, 452, 453, 456, 458, 463, 464, 465, 468, 476, 490, 499, 504, 508, or any combination thereof to the amino acid sequence of SEQ ID NO:3, and the variant polypeptide has beta-amylase activity;
- (c) variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:4, wherein the variant polypeptide has at least one single amino acid modification to the amino acid sequence of SEQ ID NO:4, at an amino acid residue position number:
- 16, 19, 24, 25, 27, 28, 48, 83, 101, 105, 107, 119, 141, 143, 145, 146, 147, 153, 155, 172, 175, 179, 197, 201, 203, 205, 206, 215, 219, 220, 221, 230, 273, 280, 286, 319, 322, 364, 366 369, 398, 399, 438, 440, 446, 452, 453, 456, 458, 463, 464, 465, 468, 476, 490, 499, 504, 508, or any combination thereof to the amino acid sequence of SEQ ID NO:4, and the variant polypeptide has beta-amylase activity;
- (d) the variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:5, wherein the variant polypeptide has at least one single amino acid modification to the amino acid sequence of SEQ ID NO:5, at an amino acid residue position number:
- 16, 19, 24, 25, 27, 28, 48 83, 101, 105, 107, 119, 141, 143, 145, 146, 147, 153, 155, 172, 175, 179, 197, 201, 203, 205, 206, 215, 219, 220, 221, 230, 273, 280, 286, 319, 322, 364, 366 369, 398, 399, 438, 440, 446, 452, 453, 456, 458, 463, 464, 465, 468, 476, 490, 499, 504, 508, or any combination thereof to the amino acid sequence of SEQ ID NO:5, and the variant polypeptide has beta-amylase activity;
- (e) the variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:6, wherein the variant polypeptide has at least one single amino acid modification to the amino acid sequence of SEQ ID NO:6, at an amino acid residue position number:
- 16, 19, 24, 25, 27, 28, 48, 83, 101, 105, 107, 119, 141, 143, 145, 146, 147, 153, 155, 172, 175, 179, 197, 201, 203, 205, 206, 215, 219, 220, 221, 230, 273, 280, 286, 319, 322, 364, 366 369, 398, 399, 438, 440, 446, 452, 453, 456, 458, 463, 464, 465, 468, 476, 490, 499, 504, 508, or any combination thereof to the amino acid sequence of SEQ ID NO:6, and the variant polypeptide has beta-amylase activity;
- and, (f) the variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:7, wherein the variant polypeptide has at least one single amino acid modification to the amino acid sequence of SEQ ID NO:7, at an amino acid residue position number 48, 51, 56, 57, 59, 60, 80, 115, 133, 137, 139, 151, 173, 175, 177, 178, 179, 185, 187, 204, 207, 211, 229, 233,235, 237, 238, 247, 251, 252, 253, 262, 305, 231, 318, 351, 354, 396, 398, 401, 430, 431, 470, 472, 478, 484, 485, 488, 490, 495, 496, 497, 500, 508, 522, 531, 536, 540, or any combination thereof to the amino acid sequence of SEQ ID NO:7, and the variant polypeptide has beta-amylase activity.
8 more elements
A variant polypeptide having beta-amylase activity, wherein the variant polypeptide is selected from the group consisting of:
- (i) the variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:2, wherein the variant polypeptide has a combination of amino acid modifications to the amino acid sequence of SEQ ID NO:2, and the combination is selected from the group consisting of:
- (a1) D19I, L27C, A141R, A364P, N369P, S398P;
- (b1) D19I, L27C, I28A, S145N, G203I, S220L, A364P, N369P, S398P;
- (c1) D19I, L27H, Q221M;
- (d1) D25K, A364P, N369P, S398P;
- (e1) D25K, A364P, N369P, S398P;
- (f1) D25K, G203I, A364P, N369P, S398P;
- (g1) D25K, I28A, S220L, Q221M, A364P, N369P;
- (h1) D25K, L27C, G203I, A364P, N369P, S398P;
- (i1) D25K, L27C, G203I, A364P, N369P, S398P;
- (j1) D25K, L27C, G203I, Q221M, A364P, N369P, S398P;
- (k1) D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (l1) D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (m1) D25K, L27C, S145N, S220L, A364P, N369P, S398P;
- (n1) D25K, L27C, S220L, A364P, N369P, S398P;
- (o1) D25P, L27H, I28A, Q221M;
- (p1) G203I, A364P, N369P, S398P;
- (q1) K24E, D25K, L27C, A364P, N369P;
- (r1) K24E, D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (s1) K24E, D25P, L27H, A141R, G203I, S220L, S398P;
- (t1) K24E, L27H, I28A, S220L, A364P, N369P, S398P;
- (u1) N143D, A197T;
- (v1) S220L, A364P, N369P, S398P;
- (w1) T101N, D399M;
- (X1) D25K, A364P, N369P, S398P, P463T;
- (y1) D25K, A364P, N369P, S398P, N438Y, N464D, P476L;
- (z1) D25K, A364P, N369P, S398P, P463L, Y465N, W468C;
- (a2) D25K, A364P, N369P, S398P, A456S;
- (b2) D25K, A364P, N369P, S398P, N438Y, Y440N;
- (c2) D25K, A364P, N369P, S398P, G458D;
- (d2) D25K, A364P, N369P, S398P, S508T;
- (e2) D25K, A364P, N369P, S398P, T504N;
- (f1) D25K, A364P, N369P, S398P, S490T;
- (g2) D25K, A364P, N369P, S398P, S499P;
- (h2) D25K, A364P, N369P, S398P, N452D;
- (i2) D25K, A364P, N369P, S398P, N438S;
- (j2) D25K, A364P, N369P, S398P, T453K;
- (k2) D25K, A364P, N369P, S398P, S446P;
- (l2) D25K, A364P, N369P, S398P, W468C;
- (m2) D25K, L27C, S220L, A364P, N369P, S398P, K153E, K201E;
- (n2) D25K, L27C, S220L, A364P, N369P, S398P, E48D, N143Y, S146P, K201E;
- (o2) D25K, L27C, S220L, A364P, N369P, S398P, N107S, S172T, W175R;
- (p2) D25K, L27C, S220L, A364P, N369P, S398P, Q105L, N119D;
- (q2) D25K, L27C, S220L, A364P, N369P, S398P, P463T;
- (r2) D25K, L27C, S220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (s2) D25K, L27C, S220L, A364P, N369P, S398P, P463L, Y465N, W468C;
- (t2) D25K, L27C, K153E, K201E, S220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (u2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, P463T;
- (v2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, N438Y, N464D, P476L;
- and (w2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, S398P, P463L, Y465N, W468C;
- wherein the variant polypeptide has beta-amylase activity;
- (ii) the variant polypeptide is an amino acid sequence that is at least 99.4% identical to the amino acid sequence as set forth in SEQ ID NO:3, wherein the variant polypeptide has a combination of amino acid modifications to the amino acid sequence of SEQ ID NO:3, and the combination is selected from the group consisting of:
- (a1) D19I, L27C, A141R, A364P, N369P, S398P;
- (b1) D19I, L27C, I28A, S145N, G203I, S220L, A364P, N369P, S398P;
- (e1) D19I, L27H, Q221M;
- (d1) D25K, A364P, N369P, S398P;
- (e1) D25K, A364P, N369P, S398P;
- (f1) D25K, G203I, A364P, N369P, S398P;
- (g1) D25K, I28A, S220L, Q221M, A364P, N369P;
- (h1) D25K, L27C, G203I, A364P, N369P, S398P;
- (i1) D25K, L27C, G203I, A364P, N369P, S398P;
- (j1) D25K, L27C, G203I, Q221M, A364P, N369P, S398P;
- (k1) D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (l1) D25K, L27C, I28A, A41R, A364P, N369P, S398P;
- (m1) D25K, L27C, S145N, S220L, A364P, N369P, S398P;
- (n1) D25K, L27C, S220L, A364P, N369P, S398P;
- (o1) D25P, L27H, I28A, Q221M;
- (p1) G203I, A364P, N369P, S398P;
- (q1) K24E, D25K, L27C, A364P, N369P;
- (r1) K24E, D25K, L27C, I28A, A41R, A364P, N369P, S398P;
- (s1) K24E, D25P, L27H, A41R, G203I, S220L, S398P;
- (t1) K24E, L27H, I28A, S220L, A364P, N369P, S398P;
- (u1) N143D, A197T;
- (v1) S220L, A364P, N369P, S398P;
- (w1) T101N, D399M;
- (X1) D25K, A364P, N369P, S398P, P463T;
- (y1) D25K, A364P, N369P, S398P, N438Y, N464D, P476L;
- (z1) D25K, A364P, N369P, S398P, P463L, Y465N, W468C;
- (a2) D25K, A364P, N369P, S398P, A456S;
- (b2) D25K, A364P, N369P, S398P, N438Y, Y440N;
- (c2) D25K, A364P, N369P, S398P, G458D;
- (d2) D25K, A364P, N369P, S398P, S508T;
- (e2) D25K, A364P, N369P, S398P, T504N;
- (f1) D25K, A364P, N369P, S398P, S490T;
- (g2) D25K, A364P, N369P, S398P, S499P;
- (h2) D25K, A364P, N369P, S398P, N452D;
- (i2) D25K, A364P, N369P, S398P, N438S;
- (j2) D25K, A364P, N369P, S398P, T453K;
- (k2) D25K, A364P, N369P, S398P, S446P;
- (l2) D25K, A364P, N369P, S398P, W468C;
- (m2) D25K, L27C, S220L, A364P, N369P, S398P, K153E, K201E;
- (n2) D25K, L27C, S220L, A364P, N369P, S398P, E48D, N143Y, S146P, K201E;
- (o2) D25K, L27C, S220L, A364P, N369P, S398P, N107S, S172T, W175R;
- (p2) D25K, L27C, S220L, A364P, N369P, S398P, Q105L, N119D;
- (q2) D25K, L27C, S220L, A364P, N369P, S398P, P463T;
- (r2) D25K, L27C, S220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (s2) D25K, L27C, S220L, A364P, N369P, S398P, P463L, Y465N, W468C;
- (t2) D25K, L27C, K153E, K201E, S220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (u2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, P463T;
- (v2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, N438Y, N464D, P476L;
- and (w2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, S398P, P463L, Y465N, W468C;
- wherein the variant polypeptide has beta-amylase activity;
- (iii) the variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:4, wherein the variant polypeptide has a combination of amino acid modifications to the amino acid sequence of SEQ ID NO:4, and the combination is selected from the group consisting of:
- (a1) D19I, L27C, A141R, A364P, N369P, S398P;
- (b1) D19I, L27C, I28A, S145N, G203I, S220L, A364P, N369P, S398P;
- (c1) D19I, L27H, Q221M;
- (d1) D25K, A364P, N369P, S398P;
- (e1) D25K, A364P, N369P, S398P;
- (f1) D25K, G203I, A364P, N369P, S398P;
- (g1) D25K, I28A, S220L, Q221M, A364P, N369P;
- (h1) D25K, L27C, G203I, A364P, N369P, S398P;
- (i1) D25K, L27C, G203I, A364P, N369P, S398P;
- (j1) D25K, L27C, G203I, Q221M, A364P, N369P, S398P;
- (k1) D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (l1) D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (m1) D25K, L27C, S145N, S220L, A364P, N369P, S398P;
- (n1) D25K, L27C, S220L, A364P, N369P, S398P;
- (o1) D25P, L27H, I28A, Q221M;
- (p1) G203I, A364P, N369P, S398P;
- (q1) K24E, D25K, L27C, A364P, N369P;
- (r1) K24E, D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (s1) K24E, D25P, L27H, A141R, G203I, S220L, S398P;
- (t1) K24E, L27H, I28A, S220L, A364P, N369P, S398P;
- (u1) N143D, A197T;
- (v1) S220L, A364P, N369P, S398P;
- (w1) T101N, D399M;
- (X1) D25K, A364P, N369P, S398P, P463T;
- (y1) D25K, A364P, N369P, S398P, N438Y, N464D, P476L;
- (z1) D25K, A364P, N369P, S398P, P463L, Y465N, W468C;
- (a2) D25K, A364P, N369P, S398P, A456S;
- (b2) D25K, A364P, N369P, S398P, N438Y, Y440N;
- (c2) D25K, A364P, N369P, S398P, G458D;
- (d2) D25K, A364P, N369P, S398P, S508T;
- (e2) D25K, A364P, N369P, S398P, T504N;
- (f1) D25K, A364P, N369P, S398P, S490T;
- (g2) D25K, A364P, N369P, S398P, S499P;
- (h2) D25K, A364P, N369P, S398P, N452D;
- (i2) D25K, A364P, N369P, S398P, N438S;
- (j2) D25K, A364P, N369P, S398P, T453K;
- (k2) D25K, A364P, N369P, S398P, S446P;
- (l2) D25K, A364P, N369P, S398P, W468C;
- (m2) D25K, L27C, S220L, A364P, N369P, S398P, K153E, K201E;
- (n2) D25K, L27C, S220L, A364P, N369P, S398P, E48D, N143Y, S146P, K201E;
- (o2) D25K, L27C, S220L, A364P, N369P, S398P, N107S, S172T, W175R;
- (p2) D25K, L27C, S220L, A364P, N369P, S398P, Q105L, N119D;
- (q2) D25K, L27C, S220L, A364P, N369P, S398P, P463T;
- (r2) D25K, L27C, S220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (s2) D25K, L27C, S220L, A364P, N369P, S398P, P463L, Y465N, W468C;
- (t2) D25K, L27C, K153E, K201E, S220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (u2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, P463T;
- (v2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, N438Y, N464D, P476L;
- and (w2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, S398P, P463L, Y465N, W468C;
- wherein the variant polypeptide has beta-amylase activity;
- (iv) the variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:5, wherein the variant polypeptide has a combination of amino acid modifications to the amino acid sequence of SEQ ID NO:5, and the combination is selected from the group consisting of:
- (a1) D19I, L27C, A141R, A364P, N369P, S398P;
- (b1) D19I, L27C, I28A, S145N, G203I, C220L, A364P, N369P, S398P;
- (c1) D19I, L27H, Q221M;
- (d1) D25K, A364P, N369P, S398P;
- (e1) D25K, A364P, N369P, S398P;
- (f1) D25K, G203I, A364P, N369P, S398P;
- (g1) D25K, I28A, C220L, Q221M, A364P, N369P;
- (h1) D25K, L27C, G203I, A364P, N369P, S398P;
- (i1) D25K, L27C, G203I, A364P, N369P, S398P;
- (j1) D25K, L27C, G203I, Q221M, A364P, N369P, S398P;
- (k1) D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (l1) D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (m1) D25K, L27C, S145N, C220L, A364P, N369P, S398P;
- (n1) D25K, L27C, C220L, A364P, N369P, S398P;
- (o1) D25P, L27H, I28A, Q221M;
- (p1) G203I, A364P, N369P, S398P;
- (q1) K24E, D25K, L27C, A364P, N369P;
- (r1) K24E, D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (s1) K24E, D25P, L27H, A141R, G203I, C220L, S398P;
- (t1) K24E, L27H, I28A, C220L, A364P, N369P, S398P;
- (u1) N143D, A197T;
- (v1) C220L, A364P, N369P, S398P;
- (w1) T101N, D399M;
- (X1) D25K, A364P, N369P, S398P, P463T;
- (y1) D25K, A364P, N369P, S398P, N438Y, N464D, P476L;
- (z1) D25K, A364P, N369P, S398P, P463L, Y465N, W468C;
- (a2) D25K, A364P, N369P, S398P, A456S;
- (b2) D25K, A364P, N369P, S398P, N438Y, Y440N;
- (c2) D25K, A364P, N369P, S398P, G458D;
- (d2) D25K, A364P, N369P, S398P, S508T;
- (e2) D25K, A364P, N369P, S398P, T504N;
- (f1) D25K, A364P, N369P, S398P, S490T;
- (g2) D25K, A364P, N369P, S398P, S499P;
- (h2) D25K, A364P, N369P, S398P, N452D;
- (i2) D25K, A364P, N369P, S398P, N438S;
- (j2) D25K, A364P, N369P, S398P, T453K;
- (k2) D25K, A364P, N369P, S398P, S446P;
- (l2) D25K, A364P, N369P, S398P, W468C;
- (m2) D25K, L27C, C220L, A364P, N369P, S398P, K153E, K201E;
- (n2) D25K, L27C, C220L, A364P, N369P, S398P, E48D, N143Y, S146P, K201E;
- (o2) D25K, L27C, C220L, A364P, N369P, S398P, N107S, S172T, W175R;
- (p2) D25K, L27C, C220L, A364P, N369P, S398P, Q105L, N119D;
- (q2) D25K, L27C, C220L, A364P, N369P, S398P, P463T;
- (r2) D25K, L27C, C220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (s2) D25K, L27C, C220L, A364P, N369P, S398P, P463L, Y465N, W468C;
- (t2) D25K, L27C, K153E, K201E, C220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (u2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, P463T;
- (v2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, N438Y, N464D, P476L;
- and (w2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, S398P, P463L, Y465N, W468C;
- wherein the variant polypeptide has beta-amylase activity;
- (vi) the variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:6, wherein the variant polypeptide has a combination of amino acid modifications to the amino acid sequence of SEQ ID NO:6, and the combination is selected from the group consisting of:
- (a1) D19I, L27C, A141R, A364P, N369P, S398P;
- (b1) D19I, L27C, I28A, S145N, G203I, S220L, A364P, N369P, S398P;
- (c1) D19I, L27H, Q221M;
- (d1) D25K, A364P, N369P, S398P;
- (e1) D25K, A364P, N369P, S398P;
- (f1) D25K, G203I, A364P, N369P, 5398P;
- (g1) D25K, I28A, S220L, Q221M, A364P, N369P;
- (h1) D25K, L27C, G203I, A364P, N369P, S398P;
- D25K, L27C, G203I, A364P, N369P, S398P;
- (j1) D25K, L27C, G203I, Q221M, A364P, N369P, S398P;
- (k1) D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (l1) D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (m1) D25K, L27C, S145N, S220L, A364P, N369P, S398P;
- (n1) D25K, L27C, S220L, A364P, N369P, S398P;
- (o1) D25P, L27H, I28A, Q221M;
- (p1) G203I, A364P, N369P, S398P;
- (q1) K24E, D25K, L27C, A364P, N369P;
- (r1) K24E, D25K, L27C, I28A, A141R, A364P, N369P, S398P;
- (s1) K24E, D25P, L27H, A141R, G203I, S220L, S398P;
- (t1) K24E, L27H, I28A, S220L, A364P, N369P, S398P;
- (u1) N143D, A197T;
- (v1) S220L, A364P, N369P, S398P;
- (w1) T101N, D399M;
- (X1) D25K, A364P, N369P, S398P, P463T;
- (y1) D25K, A364P, N369P, S398P, N438Y, N464D, P476L;
- (z1) D25K, A364P, N369P, S398P, P463L, Y465N, W468C;
- (a2) D25K, A364P, N369P, S398P, A456S;
- (b2) D25K, A364P, N369P, S398P, N438Y, Y440N;
- (c2) D25K, A364P, N369P, S398P, G458D;
- (d2) D25K, A364P, N369P, S398P, S508T;
- (e2) D25K, A364P, N369P, S398P, T504N;
- (f1) D25K, A364P, N369P, S398P, S490T;
- (g2) D25K, A364P, N369P, S398P, S499P;
- (h2) D25K, A364P, N369P, S398P, N452D;
- (i2) D25K, A364P, N369P, S398P, N438S;
- (j2) D25K, A364P, N369P, S398P, T453K;
- (k2) D25K, A364P, N369P, S398P, S446P;
- (l2) D25K, A364P, N369P, S398P, W468C;
- (m2) D25K, L27C, S220L, A364P, N369P, S398P, K153E, K201E;
- (n2) D25K, L27C, S220L, A364P, N369P, S398P, E48D, N143Y, Si46P, K201E;
- (o2) D25K, L27C, S220L, A364P, N369P, S398P, N107S, S172T, W175R;
- (p2) D25K, L27C, S220L, A364P, N369P, S398P, Q105L, Ni 19D;
- (q2) D25K, L27C, S220L, A364P, N369P, S398P, P463T;
- (r2) D25K, L27C, S220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (s2) D25K, L27C, S220L, A364P, N369P, S398P, P463L, Y465N, W468C;
- (t2) D25K, L27C, K153E, K201E, S220L, A364P, N369P, S398P, N438Y, N464D, P476L;
- (u2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, P463T;
- (v2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, N438Y, N464D, P476L;
- and (w2) D25K, L27C, G203I, Q221M, A364P, N369P, S398P, S398P, P463L, Y465N, W468C;
- wherein the variant polypeptide has beta-amylase activity;
- (vii) the variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:7, wherein the variant polypeptide has a combination of amino acid modifications to the amino acid sequence of SEQ ID NO:7, and the combination is selected from the group consisting of:
- (a1) D51I, L59C, A173R, A396P, N401P, S430P;
- (b1) D51I, L59C, I60A, S177N, G235I, S252L, A3% P, N401P, S430P;
- (c1) D51I, L59H, Q253M;
- (d1) D57K, A3% P, N401P, S430P;
- (e1) D57K, A3% P, N401P, S430P;
- (f1) D57K, G235I, A396P, N401P, S430P;
- (g1) D57K, I60A, S252L, Q253M, A3% P, N401P;
- (h1) D57K, L59C, G235I, A3% P, N401P, S430P;
- (i1) D57K, L59C, G235I, A396P, N401P, S430P;
- (j1) D57K, L59C, G235I, Q253M, A396P, N401P, S430P;
- (k1) D57K, L59C, I60A, A173R, A3% P, N401P, S430P;
- (l1) D57K, L59C, I60A, A173R, A3% P, N401P, S430P;
- (m1) D57K, L59C, S177N, S252L, A3% P, N401P, S430P;
- (n1) D57K, L59C, S252L, A3% P, N401P, S430P;
- (o1) D57P, L59H, I60A, Q253M;
- (p1) G235I, A396P, N401P, S430P;
- (q1) K56E, D57K, L59C, A3% P, N369P;
- (r1) K56E, D57K, L59C, I60A, A173R, A3% P, N401P, S430P;
- (s1) K56E, D57P, L59H, A173R, G235I, S252L, S430P;
- (t) K56E, L59H, I60A, S252L, A3% P, N401P, S430P;
- (u1) N175D, A229T;
- (v1) S252L, A3% P, N401P, S430P;
- (w1) T133N, D431M;
- (x1) D57K, A3% P, N401P, S430P, P495T;
- (y1) D57K, A3% P, N401P, S430P, N470Y, N496D, P508L;
- (z1) D57K, A396P, N401P, S430P, P495L, Y497N, W500C;
- (a2) D57K, A3% P, N401P, S430P, A488S;
- (b2) D57K, A3% P, N401P, S430P, N470Y, Y472N;
- (c2) D57K, A3% P, N401P, S430P, G490D;
- (d2) D57K, A3% P, N401P, S430P, S540T;
- (e2) D57K, A3% P, N401P, S430P, T540N;
- (f1) D57K, A396P, N401P, S430P, S522T;
- (g2) D57K, A3% P, N401P, S430P, S531P;
- (h2) D57K, A3% P, N401P, S430P, N484D;
- (i2) D57K, A3% P, N401P, S430P, N470S;
- (j2) D57K, A3% P, N401P, S430P, T485K;
- (k2) D57K, A3% P, N401P, S430P, S478P;
- (l2) D57K, A3% P, N401P, S430P, W500C;
- (m2) D57K, L59C, S252L, A396P, N401P, S430P, K185E, K233E;
- (n2) D57K, L59C, S252L, A3% P, N401P, S430P, E48D, N175Y, S178P, K233E;
- (o2) D57K, L59C, S252L, A3% P, N401P, S430P, N139S, S204T, W207R;
- (p2) D57K, L59C, S252L, A3% P, N401P, S430P, Q137L, N151D;
- (q2) D57K, L59C, S252L, A3% P, N401P, S430P, P495T;
- (r2) D57K, L59C, S252L, A3% P, N401P, S430P, N470Y, N4% D, P508L;
- (s2) D57K, L59C, S252L, A3% P, N401P, S430P, P495L, Y497N, W500C;
- (t2) D57K, L59C, K185E, K233E, S252L, A3% P, N401P, S430P, N470Y, N496D, P508L;
- (u2) D57K, L59C, G235I, Q253M, A396P, N401P, S430P, P495T;
- (v2) D57K, L59C, G235I, Q253M, A3% P, N401P, S430P, N470Y, N4% D, P508L;
- (w2) D57K, L59C, G235I, Q253M, A396P, N401P, S430P, P495L, Y497N, W500C;
- wherein the variant polypeptide has beta-amylase activity.
303 more elements
A variant polypeptide having beta-amylase activity, wherein the variant polypeptide is an amino acid sequence that is at least 95% identical to the amino acid sequence as set forth in SEQ ID NO:2, and the variant polypeptide has an increase in enzyme activity, thermostability, pH-stability, or any combination thereof when compared to the beta-amylase of SEQ ID NO:2.
Dependencies are inferred from the claim text.